Skip to main content
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
Targeted therapy for BRAFV600E malignant astrocytoma.
Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
Principles and current strategies for targeting autophagy for cancer treatment.
Targeting Ras in myeloid leukemias.
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors.
Testing of new agents in childhood cancer preclinical models: meeting summary.
Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.